Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jul;21(1):303–309. doi: 10.1128/iai.21.1.303-309.1978

Characteristics of an adenovirus type 19 conjunctivitis isolate and evidence for a subgroup associated with epidemic conjunctivitis.

J C Newland, M K Cooney
PMCID: PMC421990  PMID: 30698

Abstract

Although adneovirus type 19 (Ad19) was first described in 1955, this virus was not associated with disease until its isolation from outbreaks of conjunctivitis in 1973. A strain of Ad19 isolated from a case of conjunctivitis in Seattle in 1974 was compared with the reference strain (3911). Plaque number and size were enhanced by 30 mM MgCl2. Low pH and chloroform treatment had no effect on either strain's activity, but the two strains were sensitive to pH 8. Growth curves were characteristic of adenoviruses, but differences were seen in the amount of virus released. The ratios of particles to plaque-forming units (approximately 10,000:1) were similar for both. Both virus preparations contained high concentrations of group-specific complement-fixing antigen. Cross-reactions were seen by hemagglutination inhibition and immunoelectron microscopy between antisera to Ad8, Ad9, and Ad10 versus both strains of Ad19, but were not seen by neutralization. We would like to suggest, based on exclusive conjunctivitis association and cross-reactions, that the four cross-reacting serotypes, Ad8, Ad9, Ad10, and Ad19, represent a subgroup of adenoviruses specfically associated with conjunctivitis.

Full text

PDF
306

Images in this article

307Image
on p.307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL S. D., Jr, McCOMB D. E., MURRAY E. S., CHANG R. S., SNYDER J. C. Adenoviruses isolated from Saudi Arabia. I. Epidemiologic features. Am J Trop Med Hyg. 1959 Jul;8(4):492–500. doi: 10.4269/ajtmh.1959.8.492. [DOI] [PubMed] [Google Scholar]
  2. Bell E. J., Winton F. W. Letter: Keratoconjunctivitis caused by adenovirus type 19. Br Med J. 1975 Jan 11;1(5949):91–91. doi: 10.1136/bmj.1.5949.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burns R. P., Potter M. H. Epidemic keratoconjunctivitis due to adenovirus type 19. Am J Ophthalmol. 1976 Jan;81(1):27–29. doi: 10.1016/0002-9394(76)90187-2. [DOI] [PubMed] [Google Scholar]
  4. Cooney M. K., Hall C. E., Fox J. P. The Seattle virus watch. 3. Evaluation of isolation methods and summary of infections detected by virus isolations. Am J Epidemiol. 1972 Oct;96(4):286–305. doi: 10.1093/oxfordjournals.aje.a121459. [DOI] [PubMed] [Google Scholar]
  5. DAWSON C., JAWETZ E., HANNA L., WINN W. E., THOMPSON C. A family outbreak of adenovirus 8 infection (epidemic keratoconjunctivitis). Am J Hyg. 1960 Nov;72:279–283. doi: 10.1093/oxfordjournals.aje.a120150. [DOI] [PubMed] [Google Scholar]
  6. Darougar S., Quinlan M. P., Gibson J. A., Jones B. R. Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol. 1977 Feb;61(2):76–85. doi: 10.1136/bjo.61.2.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Desmyter J., De Jong J. C., Slaterus K. W., Verlaeckt H. Letter: Keratoconjunctivitis caused by Adenovirus Type 19. Br Med J. 1974 Nov 16;4(5941):406–406. doi: 10.1136/bmj.4.5941.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dreizin R. S., Zolotarskaia E. E. Razdelenie adenovirusov na podgruppy v sviazi s ikh gemaggliutiniruiushchei aktivnost'iu svoistvami gemaggliutininov. Vopr Virusol. 1967 Sep-Oct;12(5):577–581. [PubMed] [Google Scholar]
  9. Fiala M., Kenny G. E. Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. J Bacteriol. 1966 Dec;92(6):1710–1715. doi: 10.1128/jb.92.6.1710-1715.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fox J. P., Hall C. E., Cooney M. K. The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol. 1977 Apr;105(4):362–386. doi: 10.1093/oxfordjournals.aje.a112394. [DOI] [PubMed] [Google Scholar]
  11. GINSBERG H. S. Characteristics of the new respiratory viruses (adenoviruses). II. Stability to temperature and pH alterations. Proc Soc Exp Biol Med. 1956 Oct;93(1):48–52. doi: 10.3181/00379727-93-22659. [DOI] [PubMed] [Google Scholar]
  12. Green M., Piña M., Kimes R. C. Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology. 1967 Mar;31(3):562–565. doi: 10.1016/0042-6822(67)90241-3. [DOI] [PubMed] [Google Scholar]
  13. Guyer B., O'Day D. M., Hierholzer J. C., Schaffner W. Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and type 19 infection. J Infect Dis. 1975 Aug;132(2):142–150. doi: 10.1093/infdis/132.2.142. [DOI] [PubMed] [Google Scholar]
  14. Hierholzer J. C. Further subgrouping of the human adenoviruses by differential hemagglutination. J Infect Dis. 1973 Oct;128(4):541–550. doi: 10.1093/infdis/128.4.541. [DOI] [PubMed] [Google Scholar]
  15. Hierholzer J. C., Gamble W. C., Dowdle W. R. Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers. J Clin Microbiol. 1975 Jan;1(1):65–74. doi: 10.1128/jcm.1.1.65-74.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hierholzer J. C., Guyer B., O'Day D., Schaffner W. Letter: Adenovirus type 19 keratoconjunctivitis. N Engl J Med. 1974 Jun 20;290(25):1436–1436. doi: 10.1056/nejm197406202902512. [DOI] [PubMed] [Google Scholar]
  17. JAWETZ E., HANNA L., SONNE M., THYGESON P. A laboratory infection with adenovirus type 8; laboratory and epidemiologic observations. Am J Hyg. 1959 Jan;69(1):13–20. doi: 10.1093/oxfordjournals.aje.a119975. [DOI] [PubMed] [Google Scholar]
  18. Jung D., Wigand R. Epidemiology of group II adenoviruses. Am J Epidemiol. 1967 Mar;85(2):311–319. doi: 10.1093/oxfordjournals.aje.a120694. [DOI] [PubMed] [Google Scholar]
  19. Luton P. Rapid adenovirus typing by immunoelectron microscopy. J Clin Pathol. 1973 Dec;26(12):914–917. doi: 10.1136/jcp.26.12.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McAllister R. M., Gilden R. V., Green M. Adenoviruses in human cancer. Lancet. 1972 Apr 15;1(7755):831–833. doi: 10.1016/s0140-6736(72)90812-4. [DOI] [PubMed] [Google Scholar]
  21. McAllister R. M., Nicolson M. O., Reed G., Kern J., Gilden R. V., Huebner R. J. Transformation of rodent cells by adenovirus 19 and other group D adenoviruses. J Natl Cancer Inst. 1969 Oct;43(4):917–923. [PubMed] [Google Scholar]
  22. Philipson L., Lonberg-Holm K., Pettersson U. Virus-receptor interaction in an adenovirus system. J Virol. 1968 Oct;2(10):1064–1075. doi: 10.1128/jvi.2.10.1064-1075.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. ROSEN L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg. 1960 Jan;71:120–128. doi: 10.1093/oxfordjournals.aje.a120085. [DOI] [PubMed] [Google Scholar]
  24. Stevens D. A., Schaeffer M., Fox J. P., Brandt C. D., Romano M. Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am J Epidemiol. 1967 Nov;86(3):617–633. doi: 10.1093/oxfordjournals.aje.a120771. [DOI] [PubMed] [Google Scholar]
  25. Taylor J. W., Chandler J. W., Cooney M. K. Letter: Acute hemorrhagic conjunctivitis associated with adenovirus Type 19. N Engl J Med. 1975 May 1;292(18):978–979. doi: 10.1056/NEJM197505012921819. [DOI] [PubMed] [Google Scholar]
  26. WIGAND R., BAUER H., LANG F., ADAM W. NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS. Arch Gesamte Virusforsch. 1965;15:188–199. doi: 10.1007/BF01257730. [DOI] [PubMed] [Google Scholar]
  27. Wigand R., Fliedner D. Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses. Arch Gesamte Virusforsch. 1968;24(3):245–256. doi: 10.1007/BF01241296. [DOI] [PubMed] [Google Scholar]
  28. Wigand R., Kümel G. The kinetics of adenovirus infection and spread in cell cultures infected with low multiplicity. Arch Virol. 1977;54(3):177–187. doi: 10.1007/BF01314784. [DOI] [PubMed] [Google Scholar]
  29. Wigand R., Schmieder J. Inhibition of adenovirus multiplication by metabolic inhibitors. Arch Gesamte Virusforsch. 1973;42(4):324–338. doi: 10.1007/BF01250713. [DOI] [PubMed] [Google Scholar]
  30. Wigand R. Serologische Beziehungen der Adenoviren der Gruppe II. Arch Gesamte Virusforsch. 1968;23(1):40–47. [PubMed] [Google Scholar]
  31. Wigand R., Wunnn W. Die Vermehrung von Adenoviren der Gruppe II in HeLa-Zellen. Arch Gesamte Virusforsch. 1967;21(1):1–10. [PubMed] [Google Scholar]
  32. Williams J. F. Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J Gen Virol. 1970 Dec;9(3):251–255. doi: 10.1099/0022-1317-9-3-251. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES